bluebird bio

Genetix Pharmaceuticals Renamed bluebird bio Genetix is a specializes in gene therapy, looking to develop breakthrough treatments for severe genetic disorders. The company’s platform treats the cause of genetic diseases by placing a healthy gene...

Founded in 1992
Homepage: http://www.bluebirdbio.com
Total money raised: $134.3M

02139 840 Memorial Drive

Cambridge
USA MA

Phone: (617) 491 5601

Updated on Apr 30, 2013
bluebird bio at CrunchBase

Nick Leschly CEO
John Maraganore Board of Directors
Past

October, 2012

bluebird bio raised $9.3M in unattributed round from California Institute for Regenerative Medicine

bluebird bio Awarded $9.3 Million From the California Institute for Regenerative Medicine to Further Gene Therapy Clinical Development    in.finance.yahoo.com

July, 2012

bluebird bio raised $60M in a Series D round from Deerfield Partners, RA Capital Management, ARCH Venture Partners, Third Rock Ventures, TVM Capital, Forbion Capital Partners, and Ramius Advisors

bluebird bio Secures $60 Million in Oversubscribed Financing    in.finance.yahoo.com

April, 2011

bluebird bio raised $30M in unattributed round from ARCH Venture Partners, Third Rock Ventures, TVM Capital, Forbion Capital Partners, and Easton Capital

bluebird bio Secures Additional $30 Million in Financing; ARCH Venture Partners Joins Investor Team    live-pr.com

March, 2011

appointed its first scientific advisory board (SAB) members today

Bluebird bio names first SAB members, expanding clinical trials    masshightech.com

Bluebird bio forms potential $4.2M deal with French Muscular Dystrophy Association    masshightech.com

December, 2010

collaborating with French firm Généthon in finding manufacturing solutions for gene therapy products and lentiviral vectors

Bluebird bio, French firm team in gene therapy manufacturing    masshightech.com

September, 2010

Genetix Pharmaceuticals Renamed bluebird bio; Announces Appointment of Nick Leschly as Chief Executive Officer    tmcnet.com

March, 2010

bluebird bio raised $35M in a Series B round from Third Rock Ventures, Genzyme Ventures, TVM Capital, Forbion Capital Partners, and Easton Capital

Genetix raises $35M to advance gene therapies    fiercebiotech.com

1992

bluebird bio was founded in 1992